Press room

Mission and Purpose

Omeza is a leading evidence-based medical technology and consumer healthcare products company based in Sarasota, FL USA. Initially focused on closing chronic wounds and preventing their recurrence, the Omeza mission is to improve healthcare efficiency one market at a time, beginning with wound care.

Customer Problem

Omeza end-users are people who have or are at risk for developing chronic wounds due to aging — exacerbated by comorbidities including diabetes, obesity, chronic venous insufficiency, peripheral artery disease and autoimmune disease. Current standard care is ineffective, with wound closure hindered by biofilm, excessive debridement, and inadequate provider training that results in stalled wounds and expensive, often ineffective advanced wound care treatments. These wounds frequently result in costly hospital admissions and amputations.


We are developing a performance-based bundle of Omeza products to treat venous leg ulcers, diabetic foot ulcers, pressure ulcers and surgical wounds. In turn helping to improve quality of life for patients, simplify evaluation and treatment protocols for providers, and reduce medical loss for payers. Initial product line includes: Omeza® skin protectant and Omeza® lidocaine lavage.

Company overview

Omeza was founded by Thomas Gardner, a seasoned global pharmaceutical and skin care executive, and Griscom (Chip) Bettle, a renowned chemical engineer and inventor. In partnership with Dr. Desmond Bell, DPM, CWS, a leader in limb salvage and lower extremity wound care, the core ingredient formulation of the Omeza product line was created to support a dramatic increase in the healing rate of Venous Leg Ulcers (VLUs) and Diabetic Foot Ulcers (DFUs).

Since the company’s formation in 2017, the first products in the initial lineup, based upon a proprietary omega oil formulation, are being launched and used in a variety of settings. From controlled consumer testing to use in physician supervised settings, the products are generating positive case studies. Formalized testing to achieve more statistically significant results will commence in Q3 2019.


Media Inquires
Omeza® Headquarters
Online @
Board of Managers


Who are the company's founders?
Where did the Omeza® name come from?
Is Omeza a public or private company?
What are Omeza's products?
Can I buy Omeza® products at the drugstore?
Since your products contain fish oil, wouldn't I get the same results putting fish oil on my skin?


  • Omeza raises $5.75 M in recent capital round
  • Product by area company now available at pharmacies
  • Omeza launches first of leading-edge skincare products
  • The healing power of omega oils on skin, wounds
  • Good Deeds: Sarasota-Manatee businesses give back
  • Dr. Desmond Bell Inducted into the Royal College of Physicians and Surgeons of Glasgow


  • eHealth Radio Network - Dr Desmond Bell - Non-healing wounds may be worse than cancer
  • eHeath Radio Network - Thomas E. Gardner - Value Based Healthcare
  • eHealth radio network - Thomas E. Gardner - Restoring skin integrity with Omeza
  • eHealth radio network - Dr. Desmond Bell - Chronic Wounds in the 21st Century

quick facts

  • Estimated 145 MILLION PEOPLE in the US have or are at risk of developing serious skin problems.
  • Skin ulceration estimated annual cost to Medicare alone is $28-32 BILLION annually.
  • The economic burden of diabetes related wounds on our healthcare system is greater than most forms of cancer.
  • The 5-year mortality rate of a non-healing foot ulcer, often related to peripheral neuropathy and peripheral arterial disease, is roughly 50%. Only lunch and pancreatic cancer have a worse diagnosis.

Suggested Discussion suggestions

The Company
The Products
The Industry

Latest News

President and COO - 40 under 40

President and COO - 40 under 40

Sarah Kitlowski is employee No. 1 at Omeza, a Sarasota-based startup focused on creating skin care and wound management products. Kitlowski connected with Omeza founders Thomas Gardner and Chip Bettle...

Read more
Omeza Expands Workforce with New Hires

Omeza Expands Workforce with New Hires

Omeza is building its core team with three new appointments in the past 30 days.  “These are important new hires in operations, marketing, finance and administration,” states Omeza President and...

Read more
Omeza Raises Additional $1.25MM; Second Capital Round Closed

Omeza Raises Additional $1.25MM; Second Capital Round Closed

Omeza, LLC successfully maxed out its current funding round limit at $7MM in July, having already raised $5.75MM as of its April 1 target.  The additional funds closed just prior...

Read more
Omeza Raises $5.75MM in Second Capital Round

Omeza Raises $5.75MM in Second Capital Round

Omeza, LLC closed on its most recent funding round March 28, exceeding its $5MM goal by $0.75MM and attracting a line-up of distinguished board members in the process. A medtech...

Read more